SciBase Holding AB (SE:SCIB)
:SCIB
Want to see SE:SCIB full AI Analyst Report?
SCIB Stock Chart & Stats
kr0.33
>-kr0.01(-1.65%)
At close: 4:00 PM EST
kr0.33
>-kr0.01(-1.65%)
Day’s Range― - ―
52-Week Rangekr0.17 - kr0.52
Previous CloseN/A
Volume1.41K
Average Volume (3M)318.73K
Market Cap
kr529.67M
Enterprise Valuekr165.56M
Total Cash (Recent Filing)kr71.25M
Total Debt (Recent Filing)kr23.93M
Price to Earnings (P/E)―
Beta-0.08
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding1,022,529,970
10 Day Avg. Volume218,776
30 Day Avg. Volume318,725
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)18.68
Price to Sales (P/S)3.07
P/FCF Ratio-1.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.08
Revenue Forecast (FY)kr69.80M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelSciBase’s go-to-market includes device placements plus usage-linked consumables and services. That creates durable, repeatable revenue streams that increase lifetime customer value, smooth revenue volatility, and support margin recovery as installed base grows over months.
Strong Top-line GrowthReported revenue growth is robust, reflecting market adoption of diagnostic offerings. Persistent top-line expansion provides the structural runway to scale fixed-cost absorption and improve operating leverage if management sustains commercial execution and converts trials into repeat usage.
Healthy Gross MarginA ~59% TTM gross margin signals strong product-level economics and pricing power in the core diagnostic business. High gross margins give the company room to invest in sales and R&D while preserving a pathway to positive operating income as revenue scales and overheads normalize.
Bears Say
Very Large Operating LossesOperating and net losses massively exceed revenue, indicating the cost base and investment pace are outstripping current commercialization. Without sustained revenue acceleration or structural cost cuts, losses will continue to impede progress toward sustainable profitability over the medium term.
Severe Cash BurnConsistent ~-85M TTM cash outflows show the business is materially cash-consuming. This persistent burn reduces runway, forces reliance on external financing, and constrains the company’s ability to invest opportunistically without raising capital, a structurally important risk.
Financing / Dilution RiskWhile leverage is moderate, equity volatility and deeply negative ROE reflect history of losses and past dilution. Continued operating losses heighten the odds of further equity raises or unfavorable financing, which would dilute shareholders and could constrain strategic autonomy.
SciBase Holding AB News
SCIB FAQ
What was SciBase Holding AB’s price range in the past 12 months?
SciBase Holding AB lowest stock price was kr0.17 and its highest was kr0.52 in the past 12 months.
What is SciBase Holding AB’s market cap?
SciBase Holding AB’s market cap is kr529.67M.
When is SciBase Holding AB’s upcoming earnings report date?
SciBase Holding AB’s upcoming earnings report date is Aug 26, 2026 which is in 94 days.
How were SciBase Holding AB’s earnings last quarter?
SciBase Holding AB released its earnings results on May 07, 2026. The company reported -kr0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.03.
Is SciBase Holding AB overvalued?
According to Wall Street analysts SciBase Holding AB’s price is currently Overvalued.
Does SciBase Holding AB pay dividends?
SciBase Holding AB does not currently pay dividends.
What is SciBase Holding AB’s EPS estimate?
SciBase Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SciBase Holding AB have?
SciBase Holding AB has 1,022,529,970 shares outstanding.
What happened to SciBase Holding AB’s price movement after its last earnings report?
SciBase Holding AB reported an EPS of -kr0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.618%.
Which hedge fund is a major shareholder of SciBase Holding AB?
Currently, no hedge funds are holding shares in SE:SCIB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SciBase Holding AB
SciBase Holding AB (SCIB) is a Swedish medical technology company that specializes in developing innovative diagnostic solutions for skin cancer detection and monitoring. The company operates primarily in the healthcare sector, focusing on non-invasive and effective diagnostic tools. Its core products leverage advanced technology, particularly electrical impedance spectroscopy, to provide dermatologists and healthcare providers with real-time information to aid in the diagnosis of skin lesions, ultimately enhancing patient outcomes.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
Luxbright AB
―
Arcoma AB
―
Neola Medical AB
―
Iconovo AB
―